GNH USA

Europe — EMA

Osteogenon (Ossein Hydroxyapatite Compound)

Ossein Hydroxyapatite Compound, the active ingredient in Osteogenon, is a bone health supplement presented as a unknown/unknown for oral use.

Request sourcing

1
Pack/s

What is Ossein Hydroxyapatite Compound?

Ossein Hydroxyapatite Compound, the active ingredient in Osteogenon, is a bone health supplement presented as a unknown/unknown for oral use. It supports skeletal health in adults and may be considered where bone mineral density support is desired. GNH USA supplies Osteogenon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Osteogenon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Ossein Hydroxyapatite Compound used for?

Osteogenon is a supplement that targets the bone health pathway. - Osteoporosis: May help the maintenance of bone density in post‑menopausal women. - Osteopenia : Supports the maintenance Ind the by the c   . - C        """"  . -    

Frequently asked questions

What  ....+
...
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ossein Hydroxyapatite Compound
Route
Oral Use
Manufacturer
Pierre Fabre Medicament
Origin
EU

Related products